| Old Articles: <Older 25251-25260 Newer> |
 |
The Motley Fool August 7, 2007 Rich Smith |
Oops, BABY Doesn't Bounce Mr. Market drops Natus Medical. Is now the time to buy in?  |
The Motley Fool August 7, 2007 Toby Shute |
Cooler Heads Prevail in Pretoria The South African government chooses not to tax Sasol's "windfall profits." After two years of waiting nervously, investors can breathe a sigh of relief.  |
The Motley Fool August 7, 2007 Brian Lawler |
Nektar Makes a Deal Nektar Therapeutics signs a deal with Bayer AG in an effort to move itself closer to profitability. In return, Bayer gets a co-promotion profit-sharing deal in the U.S., and commercialization rights elsewhere.  |
The Motley Fool August 7, 2007 Mike Cianciolo |
Foolish Forecast: Shifting Gears at Advance Auto The auto parts seller is set to report its second-quarter earnings. Investors, here is what you can expect to find.  |
The Motley Fool August 7, 2007 David Lee Smith |
Spectra Stronger Than Its Quarter Spectra Energy finds itself down 39% year-over-year in its quarterly earnings. However, this is a case where investors must look at the whole picture.  |
The Motley Fool August 7, 2007 |
Spectra Energy Spins Into the Future: Fool by Numbers The Canadian energy company released its second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool August 7, 2007 Rich Smith |
CheckFree No More Fiserv locks up a rival. Which party walks away the winner? Investors, take note.  |
The Motley Fool August 7, 2007 Markos Kaminis |
The Pantry Still Growing by Leaps and Bounds The convenience store chain grew its revenue, but margins took a hit, hurting its EPS. Investors, take note.  |
The Motley Fool August 7, 2007 Brian Lawler |
Encysive's Congested Sales Failure Encysive Pharmaceuticals releases quarterly results that reveal a company with problems. Its cost structure is way out of line for a drugmaker of its size and potential.  |
The Motley Fool August 7, 2007 Michael Leibert |
Moody's: No Chink in the Armor Despite feeling some heat, Moody's projects solid growth and maintains a strong competitive position. Investors, take note.  |
| <Older 25251-25260 Newer> Return to current articles. |